亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A Multicenter Application and Evaluation of the Oxford Classification of IgA Nephropathy in Adult Chinese Patients

医学 肾功能 内科学 队列 肾病 胃肠病学 蛋白尿 肾脏疾病 回顾性队列研究 病理 内分泌学 糖尿病
作者
Caihong Zeng,Weibo Le,Zhaohui Ni,Minfang Zhang,Lining Miao,Ping Luo,Rong Wang,Zhimei Lv,Jianghua Chen,Jiong Tian,Nan Chen,Xiaoxia Pan,Ping Fu,Zhangxue Hu,Lining Wang,Qiuling Fan,Hongguang Zheng,Dewei Zhang,Yaping Wang,Yanhong Huo
出处
期刊:American Journal of Kidney Diseases [Elsevier BV]
卷期号:60 (5): 812-820 被引量:155
标识
DOI:10.1053/j.ajkd.2012.06.011
摘要

The Oxford classification of immunoglobulin A (IgA) nephropathy (IgAN) provides a histopathologic grading system that is associated with kidney disease outcomes independent of clinical features. We evaluated the Oxford IgAN classification in a large cohort of patients from China.Retrospective study.1,026 adults with IgAN from 18 referral centers in China. Inclusion criteria and statistical analysis were similar to the Oxford study.Histologic findings of mesangial hypercellularity score, endocapillary proliferation, segmental sclerosis or adhesion, crescents, necrosis, and tubular atrophy/interstitial fibrosis. Clinical features, blood pressure, estimated glomerular filtration rate (eGFR), proteinuria, and treatment modalities.Time to a 50% reduction in eGFR or end-stage renal disease (the combined event); the rate of eGFR decline (slope of eGFR); proteinuria during follow-up.Compared with the Oxford cohort, the Chinese cohort had a lower proportion of patients with mesangial hypercellularity (43%) and endocapillary proliferation (11%), higher proportion with segmental sclerosis or adhesion (83%) and necrosis (15%), and similar proportion with crescents (48%) and tubular atrophy/interstitial fibrosis (moderate, 24%; severe, 3.3%). During a median follow-up of 53 (25th-75th percentile, 36-67) months, 159 (15.5%) patients reached the combined event. Our study showed that patients with a mesangial hypercellularity score higher than 0.5 were associated with a 2.0-fold (95% CI, 1.5-2.8; P<0.001) higher risk of the combined event than patients with a score of 0.5 or lower. Patients with tubular atrophy/interstitial fibrosis of 25%-50% and >50% versus <25% were associated with a 3.7-fold (95% CI, 2.6-5.1; P<0.001) and 15.1-fold (95% CI, 9.5-24.2; P<0.001) higher risk of the combined event, respectively. Endocapillary proliferation, glomerular crescents, and necrosis were not significant.Retrospective study; the therapeutic interventions were miscellaneous.We confirmed the associations of mesangial hypercellularity and tubular atrophy/interstitial fibrosis with kidney disease outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Owen应助honda采纳,获得10
29秒前
容嬷嬷完成签到,获得积分10
41秒前
582843216发布了新的文献求助10
44秒前
顾矜应助582843216采纳,获得30
55秒前
1分钟前
LY发布了新的文献求助10
1分钟前
lixin1924应助abletoo采纳,获得10
1分钟前
感性的寻芹完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
582843216发布了新的文献求助30
1分钟前
1分钟前
honda发布了新的文献求助10
1分钟前
潜行者完成签到 ,获得积分10
1分钟前
1分钟前
无花果应助582843216采纳,获得10
1分钟前
1分钟前
honda完成签到,获得积分10
1分钟前
bruna发布了新的文献求助30
1分钟前
flysteven92完成签到 ,获得积分10
1分钟前
2分钟前
582843216发布了新的文献求助10
2分钟前
英姑应助582843216采纳,获得10
2分钟前
2分钟前
2分钟前
582843216发布了新的文献求助10
3分钟前
科研通AI2S应助582843216采纳,获得10
3分钟前
3分钟前
淡然绝山发布了新的文献求助10
3分钟前
墨绾菩提应助582843216采纳,获得30
3分钟前
orixero应助淡然绝山采纳,获得10
4分钟前
4分钟前
4分钟前
墨绾菩提应助582843216采纳,获得10
4分钟前
4分钟前
4分钟前
GRATE完成签到 ,获得积分10
4分钟前
4分钟前
6分钟前
8888发布了新的文献求助80
6分钟前
高分求助中
Ideology and Meaning-Making under the Putin Regime 750
Introduction to Industrial/Organizational Psychology 600
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Medical Law and Ethics Tenth Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6929171
求助须知:如何正确求助?哪些是违规求助? 8617204
关于积分的说明 18277848
捐赠科研通 6351317
什么是DOI,文献DOI怎么找? 3073058
关于科研通互助平台的介绍 2107447
邀请新用户注册赠送积分活动 2050134